Apollo Endosurgery Inc Receivables Turnover Ratio (APEN), from the fourth quarter 2022 to the fourth quarter 2021 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Apollo Endosurgery inc   (NASDAQ: APEN)
 

Apollo Endosurgery Inc Accounts Receivables Turnover Ratio from the fourth quarter 2022 to the fourth quarter 2021

Quarterly Results, Trends, Rankings, Statistics


Apollo Endosurgery Inc 's ability to collect accounts receivable sequentially worsen to 5.97, indicating more challenging environment then in the third quarter 2022, but still, it is a far cry from any concerns. Apollo Endosurgery Inc 's Accounts Receivable average collection period in the Dec 31 2022 quarter, has increased to 61 days, from 59 days, in the Sep 30 2022 quarter.

If we take a look into Healthcare sector 369 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2022 from 1912 to 2722.

What is Receivable Turnover Ratio?
What is Apollo Endosurgery Inc Selling?


What is Receivable Turnover Ratio?





APEN Receivables Turnover Ratio (Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
Y / Y Receivable Change 48.75 % 14.66 % 32.3 % 34.66 % 22.57 %
Y / Y Revenue Change 31.8 % 17.84 % 39.33 % 29.56 % 26.08 %
Receivable Turnover Ratio (TTM) 5.97 6.16 6.12 6.05 6.1
APEN's Total Ranking # 2722 # 1912 # 2718 # 1930 # 2722
Accounts Receivable average collection period days 61 59 60 60 60
Seq. Receivable Change 16.22 % 3.03 % 13.14 % 9.8 % -10.42 %
Seq. Revenue Change 8.89 % 1.38 % 15.87 % 3.04 % -2.64 %


Receivable Turnover Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 118
Healthcare Sector # 370
Overall Market # 2722

Receivable Turnover Ratio Statistics
High Average Low
6.46 5.43 1.34
(Sep 30 2022)   (Mar 31 2018)






Financial Statements
Apollo Endosurgery Inc 's Accounts Receivable $ 15 Millions Visit APEN's Balance sheet
Apollo Endosurgery Inc 's Sales TTM $ 77 Millions Visit APEN's Income Statement
Sources of APEN's Revenues Visit APEN's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
APEN's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
APEN's Growth Rates APEN's Roa APEN's Inventory Turnover Ratio APEN's Dividend Comparisons
APEN's Profitability Ratios APEN's Roi APEN's Asset Turnover Ratio APEN's Dividend Growth
APEN's Valuation Ratios APEN's Roe APEN's Financial Strength Ratios APEN's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2022, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Dec 31 2022 Receivable at quarter ending Dec 31 2022
Travere Therapeutics Inc   13.98 $ 212.018  Millions$ 15.170  Millions
Corcept Therapeutics Inc  13.88 $ 401.858  Millions$ 28.953  Millions
Harrow Inc   13.77 $ 88.595  Millions$ 6.436  Millions
Burning Rock Biotech Limited  13.51 $ 81.662  Millions$ 6.044  Millions
Escalon Medical Corp   13.45 $ 10.938  Millions$ 0.813  Millions
Cano Health Inc   13.22 $ 2,738.916  Millions$ 207.142  Millions
Rayont Inc   13.20 $ 4.266  Millions$ 0.323  Millions
Galapagos Nv  13.08 $ 565.914  Millions$ 43.251  Millions
Neurometrix Inc   12.80 $ 8.256  Millions$ 0.645  Millions
Avita Medical Inc   12.58 $ 34.421  Millions$ 2.736  Millions
Merus N v   12.56 $ 41.586  Millions$ 3.311  Millions
Neptune Wellness Solutions Inc   12.51 $ 52.000  Millions$ 4.155  Millions
Invo Fertility Inc   12.47 $ 0.822  Millions$ 0.066  Millions
Tango Therapeutics Inc   12.43 $ 24.860  Millions$ 2.000  Millions
Agenus Inc  12.31 $ 98.024  Millions$ 7.961  Millions
Semler Scientific inc   12.25 $ 56.686  Millions$ 4.629  Millions
Lifeloc Technologies Inc   12.03 $ 8.482  Millions$ 0.705  Millions
International Stem Cell Corporation  11.95 $ 8.180  Millions$ 0.685  Millions
Teladoc Health Inc   11.90 $ 2,406.840  Millions$ 202.304  Millions
Myovant Sciences Ltd   11.87 $ 379.112  Millions$ 31.932  Millions
Calliditas Therapeutics Ab  11.42 $ 86.309  Millions$ 7.555  Millions
Scienture Holdings Inc   11.41 $ 10.451  Millions$ 0.916  Millions
Tg Therapeutics Inc   11.24 $ 2.785  Millions$ 0.248  Millions
Exact Sciences Corporation  11.20 $ 2,070.489  Millions$ 184.854  Millions
Cue Health Inc   11.15 $ 483.476  Millions$ 43.342  Millions
Integrated Biopharma Inc  11.10 $ 53.481  Millions$ 4.820  Millions
Sonendo Inc   11.04 $ 41.656  Millions$ 3.774  Millions
Ambrx Biopharma Inc   11.03 $ 11.911  Millions$ 1.080  Millions
Poseida Therapeutics Inc   10.92 $ 130.492  Millions$ 11.947  Millions
Palvella Therapeutics Inc   10.85 $ 25.902  Millions$ 2.387  Millions

Date modified: 2026-09-08T15:10:53+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.